Tubeless Insulin Pump Market Analysis

Tubeless Insulin Pump Market Analysis

To get key market trends

  Download Free Sample

The homecare segment accounted for USD 1.2 billion in 2022 and is set to witness notable growth in the coming years. This significant share is majorly attributed to the surging adoption of tubeless insulin pumps in home care settings. The surged pressure to limit the heightened healthcare expenses concerning diabetes management, notable developments, and access of these easy-to-use diabetes care devices is anticipated to drive the market size.

• Further, the emergence of user-friendly and easy-to-use devices is set to promote the adoption rate of insulin pumps in home care settings. The devices are connected with a smartphone through bluetooth connectivity and offer useful features & reminders to the users that promote its utility.
   
• Additionally, the building community supports for diabetes care initiative offers support to diabetes patients and encourages people to opt for diabetes care at homecare settings, intending to limit the expenses. Similarly, the increased demand among the geriatric population for diabetes care services in home care settings is estimated to propel the segment trends.
   
• As a result, the emergence of advanced products that deliver ease in use are projected to fuel the product adoption in home care settings, further accelerating the market share.

The North America tubeless insulin pump market is projected to reach USD 5.5 billion by 2032. This significant market growth is majorly attributed to the facilitative reimbursement scenario, the high prevalence of diabetes, and the presence of major market players in the region.
 

• This high prevalence of diabetes in the region has led to an incremental surge in the healthcare costs directly and indirectly associated with the condition. The strong presence of leading manufacturers focusing on securing approvals and insurance coverage for their products to enhance affordability will majorly drive regional market development.
   
• Furthermore, the increasing healthcare expenditure on diabetes, high spending ability on disease management, and awareness regarding the advent of new technologies are expected to boost product adoption in North America. As a result, the aforementioned factors are expected to accelerate the market progression in the region.